Introduction to the Biclonics® format
The product candidates in the Merus pipeline are based on the Biclonics® format. Biclonics® are bispecific, full length human IgG antibodies. Merus exploits a suite of technologies integrating the generation of large panels of high quality human antibodies and their rapid conversion into thousands of Biclonics® ready for functional screening in clinically relevant assays.
Biclonics® are designed to retain the format of antibodies that are produced naturally by the immune system, retaining their favorable attributes including stability and predictability during manufacturing and long half-life and low immunogenicity during treatment of patients.
The new face of fighting cancer
For an overview of all publications, please visit the publications overview page.All publications
Aiding the battle against cancer
Robotics are the future of cancer research
People behind the science
Are you interested in joining our battle against cancer? To learn more, check out the careers section on our website!Join our team